Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Majority of Older Adults Willing to be Screened by Phone for Dementia: Study

May 1, 2015 12:15 pm | News | Comments

Nearly two-thirds of older adults were willing to undergo telephone screening for dementia, according to a new study from the Indiana University Center for Aging Research and the Regenstrief Institute. Willingness to be screened by phone did not differ by sex, age or race. Read more...


Biotech Workers Win $58 Million Lottery Drawing, to Split Prize

May 1, 2015 12:06 pm | by Seth Augenstein, Digital Reporter | News | Comments

A group of 16 biotech workers at an office in Manhattan won a $58 million Mega Millions jackpot drawing this week, according to multiple reports. Read more...


Apple's ResearchKit - The Real Impact on Clinical Trials

May 1, 2015 11:57 am | by Merrilyn Datta, Ph.D., President and General Manager, Definiens | Articles | Comments

Apple recently released news about its new ResearchKit, a medical platform that intends to turn the iPhone and HealthKit into diagnostic tools. The technology, which enables researchers to create apps that gather new types of health data from users who opt-in, has gotten quite a bit of attention throughout the healthcare and technology communities. Read more...


Braeburn Expands Pipeline to Include Two Schizophrenia Treatments

May 1, 2015 11:47 am | News | Comments

Braeburn Pharmaceuticals announced today that it has expanded its current therapeutic focus beyond addiction and pain to include schizophrenia and other serious psychiatric disorders. Read more..


Bayer's Contraception Safe, Effective: 5-Year Follow-Up Study

May 1, 2015 11:42 am | News | Comments

Bayer HealthCare announced today that a study published online this week in The Journal of Minimally Invasive Gynecology reinforces findings from previous clinical studies that support the effectiveness and safety of the Essure inserts and procedure for hysteroscopic sterilization, or permanent birth control. Read more...


Medicare Data Show Contrast in Generic, Brand Prescribing

May 1, 2015 11:32 am | by Lauran Neergaard, AP Medical Writer | News | Comments

The most-used medicines in Medicare's prescription drug program are generics, but the program spends the most on brand-name drugs, led by the heartburn treatment Nexium, according to an unprecedented release of government data on Thursday. Read more...


AIT's Cystic Fibrosis Treatment Granted European Orphan Drug Designation

May 1, 2015 9:20 am | News | Comments

Advanced Inhalation Therapies Ltd (AIT), a leading anti-microbial therapeutic company, announced that the European Commission, acting on the recommendation from the Committee for Orphan Medicinal Products of the European Medicines Agency, granted orphan medicinal product designation to AIT-CF, the Company's proprietary high dose formulation of nitric oxide (NO), for the treatment of cystic fibrosis. Read more...


Is the World Failing in Fight Against Antibiotic Resistance?

May 1, 2015 9:09 am | by Bevin Fletcher, Associate Editor | News | Comments

Antimicrobial resistance is a growing global concern, one that the World Health Organization (WHO) is asking countries to ramp up efforts to prepare for. While many countries have strategies to address the issue, there are still a large number that do not have clear plans to curb misuse and reduce the spread of antimicrobial resistance, according to a new WHO report. Read more...


Genocea's GEN-003 in Prime Position to Lead GH Vaccine Space

April 30, 2015 4:50 pm | by Daian Cheng, Ph.D., GlobalData Infectious Disease Analyst | News | Comments

Genocea Biosciences’ investigational genital herpes (GH) vaccine, GEN-003, is better positioned to compete in the future GH treatment space, despite being slightly behind Agenus’ HerpV in clinical development, according to GlobalData. Read more..


AOP Orphan Launches Lojuxta to the Austrian Market

April 30, 2015 4:45 pm | News | Comments

The Austrian pharmaceutical company AOP Orphan, a European pioneer in the field of rare diseases, is launching Lojuxta into the Austrian market. Lojuxta was authorized by the EMA (European Medical Agency) in July 2013. Read more...


Pressure Grows to End Blanket Bans on Gay Men Blood Donors

April 30, 2015 4:29 pm | by Associated Press | News | Comments

The European Union's top court on Wednesday joined a growing chorus of voices questioning whether it still makes sense to forever bar all gay men from donating blood. Read more...


FDA Seeks More Data on Safety of Hospital Hand Cleaners

April 30, 2015 4:22 pm | by Matthew Perrone, AP Health Writer | News | Comments

To fight infections, hospital workers can hit the hand sanitizer a hundred times or more a day. Now, the government wants more study of whether that is safe and how well it actually fights the spread of germs. Read more...

Researchers Discover How Aspirin Fights Cancer

April 30, 2015 1:57 pm | by University of Minnesota | News | Comments

Taking aspirin reduces a person’s risk of colorectal cancer, but the molecular mechanisms involved have remained unknown until a recent discovery by The Hormel Institute, affiliated with the University of Minnesota. Read more...


FDA Approves Injection for Melting Away Double-Chin Fat

April 30, 2015 1:50 pm | by Associated Press | News | Comments

The Food and Drug Administration said Wednesday it approved an injection designed to melt away double-chin fat. Read more...


The Prospect of Drugs to Treat Gluten Sensitivity

April 30, 2015 1:31 pm | by Stephanie Guzowski, Editor | News | Comments

Pharmaceutical companies are working to develop treatments as a first line of defense against gluten-sensitive symptoms — including abdominal pain, bloating, diarrhea, headaches and fatigue. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.